α′,β′-epoxyketone peptide which specifically inhibits proteasome activity. Isoln from actinomycetes: M. Konishi et al., EP 411660; eidem, US 5071957 (both 1991 to Bristol-Myers); and characterization: M. Hanada et al., J. Antibiot. 45, 1746 (1992). Total synthesis: N. Sin et al., Bioorg. Med. Chem. Lett. 9, 2283 (1999). Proteasome selectivity and antiinflammatory activity: L. Meng et al., Proc. Natl. Acad. Sci. USA 96, 10403 (1999). Crystal structure and mechanism of selectivity: M. Groll et al., J. Am. Chem. Soc. 122, 1237 (2000). Use as inhibitor to modulate antigen presentation: K. Schwarz et al., J. Immunol. 164, 6147 (2000).